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Non-technical Summary
The recent decade has shown a surge of firms globalising their innovation activities. This means that these firms have enlarged the number of countries where they perform R&D projects. Hence, for more and more firms R&D is no longer a purely domestic activity. A major motive underlying the decision to shift corporate R&D activities abroad is that firms seek to increase their chances to participate in international knowledge sharing. Absorbing knowledge from abroad is aimed at enhancing firms' innovativeness and consequently their competitiveness.
This paper aims at analysing whether a firm's innovation performance is enhanced by globalised R&D. In order to evaluate the benefits of a strategy that disperses R&D across foreign countries, we compare firms which have globalised their R&D activities with firms performing R&D only in their home country and with firms that are engaged in no R&D activities at all. One main novelty of our research is that we furthermore distinguish between different degrees of R&D internationalisation, that is, the number of foreign countries in which a firm has R&D laboratories. This allows us to shed light on the two competing hypotheses by Malecki (1980) and Von Hippel (1988) whether stronger dispersed international R&D activities hamper or stimulate firms' innovation. Compared to previous research that is based on patents, we use two different well-established innovation output indicators to shed light on the effects of domestic and foreign R&D: first, the introduction of new products and second their market success which is measured as the sales growth rate due to these innovations. We additionally examine whether the effects of international R&D vary with different degrees of product novelty (firm and market novelties).
The study is based on a large data set of about 2100 firms surveyed in the Mannheim Innovation Panel (MIP). The MIP represents the German part of the European-wide harmonised Community Innovation Surveys (CIS).
Based on econometric analyses, we confirm that firms with both domestic R&D and foreign R&D activities are more likely to launch new products than firms with home-based R&D only or non-R&D performers. This can be observed for both kinds of product innovations: market novelties and firm novelties. Regarding the innovation success, however, the results are not as clear-cut. Given the introduction of a firm novelty, firms with international R&D centres are also more successful than non-R&D performers and tend to be more successful than firms conducting solely domestic R&D. On the contrary, the findings reveal that the location of R&D does not matter for the success of market novelties once the market novelty has been launched to the market.
By comparing different degrees of R&D internationalisation, the study points out that firms with medium decentralised foreign R&D activities (in 2-3 countries) have a significantly higher likelihood to develop both market and firm novelties compared to firms with centralised foreign R&D in only one foreign subsidiary. A more decentralised foreign R&D organization does not exert an additional stimulating effect on the propensity to develop market novelties. On the other hand, it further increases the likelihood to develop firm novelties.
The results further elucidates that firms with medium decentralised R&D abroad achieve a higher sales growth with new products than firms which conduct R&D at home only or than firms with highly decentralised foreign R&D activities. Again, the higher sales growth rates are mainly driven by firm novelties, not by market novelties. That is, given the introduction of a market novelty, the degree of decentralisation of international R&D activities does not play a role for innovation success.
Finally, another salient finding that originates from this analysis is that German firms that have expanded their R&D only to one foreign country do not outperform firms with domestic R&D. 
Das Wichtigste in Kürze

Introduction
Firms' competitiveness depends to a great extent on their innovativeness. Due to the increasing technological complexity of products and processes and the speeding up of technological progress, firms have to source knowledge outside their boundaries in order to complement internal knowledge. This includes the use of globally available resources to foster their innovation outcomes (Kotabe, 1990) . In order to do so, firms may pursue different strategies. The two most prominent strategies are to cooperate with international partners or to establish own research and development (R&D) laboratories abroad. Fascinatingly, the recent decade has shown that corporations increasingly globalise their R&D and innovation activities by setting up own foreign R&D departments (UNCTAD, 2005) . This phenomenon can be observed for both large multinational firms (MNEs) and international SMEs. In Germany for instance, about 3% of -mainly medium-sized -innovative firms without foreign The international business literature stresses that firms pursue two main motives by performing their R&D activities abroad (Granstrand et al., 1993 , Von Zedtwitz and Gassmann, 2002 , Kuemmerle, 1997 . On the one hand, firms want to adapt their existing technologies to local demand and manufacturing conditions (exploitation strategy). On the other hand, by setting up foreign R&D subsidiaries firms seek to get access to local science and technology resources which enable them to absorb and integrate knowledge from abroad into their innovation process (home-base augmenting strategy). It has been emphasised that an effective innovation strategy needs to balance the exploitation of existing knowledge with non-local knowledge exploration (Levinthal and March, 1993) . It has further been proven that putting existing pieces of knowledge together often leads to innovations (Grant, 1996; Arora and Gambardella, 1990; Cohen and Malerba, 2001) . In this vein, the internationalisation of innovation activities may lead to the combination of existing knowledge from the firm's knowledge stock with foreign knowledge contributed by foreign local staff and spillovers from the firm's foreign business environment such as cooperating firms, competitors, customers, suppliers and scientific institutions. Given that knowledge spillovers are stronger within countries than across countries (Jaffe et al., 1993; Branstetter, 2001) , firms that perform R&D activities only in their home country are less likely to have access to foreign knowledge. Learning-by-exporting has been considered one alternative of how firms could benefit from foreign countries' expertise by engaging in local markets and interacting with customers (Clerides et al., 1998; Bernard and Jensen, 1999) . However, it is pointed out that knowledge often cannot overcome national boundaries when it is not codified (implicitly) and embedded in routines and thus hard to transfer (Kogut, 1991; Kogut and Zander, 1992) .
The potential knowledge gains from foreign R&D stand facing potential losses. They may arise due to intra-firm knowledge losses, intra-firm coordination costs of research or foregone economies of scale in conducting research. Despite the trend to internationalise R&D, the empirical evidence about the effectiveness of foreign R&D in terms of innovation output is rather scarce and limited to patents. But patent-based indicators have been heavily criticised as being a rather poor yardstick for innovative output (see, e.g., Scherer, 1965; Griliches, 1990) . In this paper we address the question whether international R&D is conducive to a firm's innovation performance.
Our research aims at extending the existing literature in three ways. First, we use two alternative well-established market-based innovation performance measures. We provide evidence of how potential gains from foreign R&D activities influence the introduction of new products ("innovation outcome") and whether firms with foreign R&D achieve a higher sales growth with innovative products ("innovation success"). Product innovations can be either new to the firm only (firm novelty) or to the market as a whole (market novelty), i.e. they greatly vary according to their degree of novelty. We suppose that foreign R&D is more crucial for developing market novelties and thus secondly examine whether the effects vary with the degree of product novelty. Since firms are expanding their number of international research locations, we finally investigate the effect of a greater decentralisation of foreign R&D locations on firms' innovation performance.
To answer our research question, we estimate knowledge production functions (Pakes and Griliches, 1984) by employing the two-step selection model proposed by Heckman (1979) .
The empirical analysis draws upon a sample of about 2100 German firms collected within the Community Innovation Surveys (CIS). In contrast to previous studies that mainly compare the contribution of foreign and home-based R&D activities for firms with globalised R&D activities, our data set allows us to liken firms with globalised R&D to firms performing R&D only at their home country or doing no R&D activities at all. The potential added value of foreign R&D to domestic R&D in comparison with only domestic R&D activities in terms of innovation performance is interesting both to scholars and managers.
To summarise our main results: We find that firms with both domestic and foreign R&D activities are more likely to launch new products (both firm and market novelties) than firms with home-based R&D only. Given the introduction of a new product they do likewise achieve a significantly higher sales growth due to this innovation than firms with home-based R&D only. This higher innovation success can be traced back to firm novelties. No differences in innovation success, however, could be found for market novelties. The degree of R&D internationalisation has an inverse u-shaped effect on both innovation performance measures. A moderate number of R&D locations abroad exert the strongest influence on innovation outcome with new products, market and firm novelties. Further, sales growth due to product innovations and firm novelties also peaks with a moderate number of R&D locations abroad. This paper continues in the following outline: section 2 presents related literature and relevant theoretical concepts which lead to the development of hypotheses. Section 3 explores the dataset and the empirical methods which are employed to test the hypotheses. Section 4 sets forth the results of the econometric analysis, and section 5 concludes with a discussion of the retrieved results and management recommendations.
Internationalisation of R&D Activities -What Do We Know so
Far?
Potential Benefits of International R&D
Multinational Enterprises (MNE) are said to be an important driver of globalization by increasing the interdependency and relatedness of geographically dispersed actors (Archibugi and Immarino, 2002) . The internationalisation of internal R&D activities has followed the internationalisation of production and other market-related business processes. Though R&D still shows the least degree of internationalisation of all business processes, it is an increasing phenomenon (see UNCTAD, 2005 The motivations of firms to internationalise their R&D have been distinguished into market seeking, technology seeking and efficiency seeking purposes. However, it is unlikely that firms are driven only by one but rather by all three motivations (DeMeyer, 1993) .
Furthermore, the objectives of R&D labs abroad have been changing over time towards knowledge sourcing and development tasks (Frost, 2001; Hakanson and Nobel, 1993; Wortmann, 1990) . The internationalisation of R&D enables firms to both widen and deepen their technological scope (Pearce and Papanastassiou, 1996) due to improved technical learning which is fostered by international R&D activities (DeMeyer, 1993) .
The resourced-based theory of the firm provides a framework to explain the differences in firms' strategic decisions, performance and competitive advantage (Grant, 1996; Liebeskind, 1996) Firms are seen as bundles of resources and capabilities that act as knowledgeintegrating institutions and develop and deploy the resource base (Grant, 1996) . Firms with superior resources will generate rents (Peteraf, 1993) . The knowledge-based view which has evolved from the resource-based theory emphasises knowledge as one of the most valuable resources. The sourcing of global knowledge would allow firms to gather additional and distinct knowledge relative to rivals and inhibits the chance to build an idiosyncratic knowledge base which can become a competitive advantage (Peteraf, 1993) . This mind-set leads to the assumption that numerous pools of knowledge are more beneficial to a firm's innovativeness than a few sources. For developing new products, however, it is ultimately essential to apply the knowledge which creates a competitive advantage in case of a successful innovation (Liebeskind, 1996; Grant, 1996) . The knowledge-based view of the firm thus implies that the foreign knowledge will increase firms' innovativeness and market success with innovations when they possess abilities necessary to utilise their knowledge base. In this regard, the corporate knowledge base also provides the foundation to decide which and how knowledge is applied in actual and future periods (Ndofor and Levitas, 2004) .
Moderating Factors of Firms' Benefits of International R&D
The potential benefits of international R&D activities are moderated by a number of factors that can hamper the outcome of international research activities. The improvement of innovation performance can only be as strong as the international R&D performing firms realise and use the chances of these ventures. Thus, it is important for firms to pursue an appropriate strategy to capture the resources abroad which are beneficial to them and to avoid losses.
First, the roles and tasks which are assigned to the innovating subsidiaries abroad affect their importance for the firms' innovation output (Iwasa and Odagiri, 2004) . The mandates of subsidiaries abroad differ by their level of R&D orientation and their focus on production support. Some R&D labs abroad have the task to absorb new knowledge and to develop new products. They act as 'knowledge augmenting' units (Kuemmerle, 1997) or 'global creators' (Nobel and Birkinshaw, 1998) . Other R&D centres abroad are characterised as 'local or global adaptors' (Nobel and Birkinshaw, 1998) , 'home base exploiting' (Kuemmerle, 1997) units or 'support laboratories' (Pearce, 1989) . Their work description comprises the support of local production, the assimilation of market knowledge and the application to customers' satisfaction (Pearce and Papanastassiou, 1996) . According to their different mandates, R&D centres abroad are likely to generate distinct degrees of quality and quantity of knowledge and skills. While some subsidiaries can contribute to the development of new products, the adaptation of existing products is aimed at enhancing the sales of innovative products on foreign markets.
The type of R&D and as a result the degree of novelty of the innovation output is also determined by the international R&D organization (Chiesa, 1996) , in particular by the degree of decentralisation. A centralised R&D organization conducts all the necessary work to develop new products in one location (Malecki, 1980) which is mostly in the firm's home country. In decentralised R&D structures, research is carried out within divisions or business units (Argyres and Silverman, 2004) . The role of decentralisation for innovation performance is ambiguous. Some scholars have argued that centralization of R&D facilities is the better R&D organization for research purposes since economies of scale and scope can be realised (Malecki, 1980; Von Zedtwitz et al., 2004) . The international decentralisation of a firm's R&D organization demands not only the management of corporate innovation efforts between the headquarter and subsidiaries but also across country borders. This involves the risk that knowledge is getting lost when it is transferred between R&D units (Szulanski 1996) or that innovation projects are duplicated in different R&D units (Gassman and Von Zedtwitz 1999).
The increase in transactions due to the internationalisation is likely to drive the costs as proposed by the transaction cost theory (Coase, 1937; Williamson, 1985) . Opponents argue that R&D decentralisation reduces managerial opportunism at a single R&D centre and empowers divisions which are closer to markets and specific demands (Von Hippel, 1988; Williamson, 1985) .
Another linchpin is the degree of international R&D decentralisation and the way of transferring and integrating international subsidiary knowledge into the corporate innovation process. The management and integration of international R&D centres are an important topic in the international business literature (Gassmann and Von Zedtwitz, 1999; Von Zedtwitz et al., 2004; Edler et al., 2002; Hemmert, 2003/04) . It has been argued that the usage of the potential global know-how does not depend on the presence of R&D labs in many parts of the world per se but more importantly on the internal firm mechanisms to integrate knowledge across R&D organizations (Singh, 2008) . Leveraging the capabilities and resources of subsidiaries across divisions and locations has been put forward to be essential for the global success of firms (Bartlett and Ghoshal, 1989; Birkinshaw et al., 1998; Frost et al., 2002; Nobel and Birkinshaw, 1998) . In our research framework, special attention has to be paid to knowledge flows within MNEs. The integration of the foreign R&D labs is on the one hand fostered by personnel contacts and exchanges between home and overseas R&D centres. It is likewise important for the transfer of locally developed knowledge to the domestic headquarter (Hakanson and Nobel, 2001; Björkmann et al., 2004) . On the other hand, the integration of the outcomes of R&D performed abroad requires a certain stage of R&D activeness of the recipient firm in the home country. Firms should carry out R&D continuously to keep up with technological developments (Tilton, 1971 ) and hereby develop their ability to identify and absorb new information from overseas R&D subsidiaries Levinthal, 1989, 1990) . These so-called absorptive capabilities of the receiving firm stimulate knowledge flows (Minbaeva et al, 2003) or act as a barrier to MNEs' knowledge flows if they lack these capabilities (Szulanski, 1996) .
A firm that sources knowledge from the host country is most likely to benefit from these activities if the foreign knowledge complements existing knowledge in its R&D labs in the home country. The complementarity concept generally means that one activity pays off more if the other activity is also carried out (Milgrom and Roberts, 1995; Schmiedeberg, 2008) .
Therefore, domestic and foreign R&D act as complements if conducted together they increase the innovation performance more than one R&D activity alone. A variety of complementarities in R&D activities have been proved to positively influence innovation success: Internal R&D has been found to be complementary to contracted R&D (Schmiedeberg, 2008) , external technology acquisition (Cassiman and Veugelers, 2006) and R&D cooperation for different industries and partners (Schmiedeberg, 2008; Veugelers, 2002, 2005; Schmidt, 2005; Arora and Gambardella, 1990) . Some of the advantages apply only to truly external firm innovation partners such as risk and cost sharing (Love and Roper, 2004) and do not count for international corporate research centres.
Notwithstanding, domestic and foreign R&D may generate synergy effects since different locations may imply access to additional sources of knowledge.
The Innovation Output of Firms with International R&D
The existing literature provides only scarce evidence whether international R&D is beneficial to firms' innovation performance. Existing studies can be distinguished whether they focus on the innovative performance of foreign R&D subsidiaries or on the effect on innovations technological impact (number of citations) and they impact upon a broader range of technological areas. However, the effect was found to be non-linear. That is, firms with strongly decentralised R&D exhibit a greater innovation impact than firms with slightly decentralised R&D. In a related study, Singh (2008) has evaluated the effect of geographically dispersed -but not necessarily international -R&D activities on the quality of innovation performance.
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Employing the number of patent citations as performance indicator he finds on average a significantly negative influence of the geographic spread of R&D activities on the innovation value. This result indicates that potential gains from access to diverse knowledge from different locations are offset by difficulties in managing and integrating knowledge across dispersed R&D units. Firms pursuing cross-regional knowledge integration strategies 2 benefit more from dispersed R&D though the overall effect remains negative. Notwithstanding, there is no evidence so far whether these results also hold for international R&D decentralisation and our research is aimed at filling this gap.
Furthermore, all above-mentioned studies are based on patent data. As it has been argued before, patents might not always be the appropriate way to capture the innovation success of R&D activities. Patents prove the result of inventive activities and display the location of inventors. However, not all patented inventions result in innovations and not all inventions and innovations are patented (Griliches, 1990; Jaffe and Trajtenberg, 2002) . Therefore, patents cover only a threshold of the results from innovation activities abroad (Levin et al., 1987; Arundel and Kabla, 1998) . Some underlying reasons are time and costs which are involved in the patent application process, as well as the aspect of knowledge disclosure by patents and the fact that only new inventions can be patented, innovations new to the firm are not patentable. In a recent study on a related topic, Criscuolo et al. (2010) have employed both patent data and firm level innovation data to investigate the effect of global engagement on innovation performance. They find that globally engaged firms (per definition multinational parent firms and multinational affiliates) applied for more patents, have a higher likelihood of introducing innovations and achieve a higher share of sales with innovations.
These results add a more international perspective to the existing innovation performance literature. However, this study merely analyses how firm status, measured by indicator variables for a multinational parent, a multinational affiliate, a local exporting firm and a local non-exporting firm, affects innovation performance. The effect of both domestic and foreign research and development activities on innovation performance remains unobserved.
Therefore our paper aims to contribute firm-level evidence about international R&D activities and their effect on innovation outcome and innovation success. 
Hypotheses
H3a: The degree of R&D internationalisation has a positive influence on the likelihood of introducing innovations (innovation outcome).
H4a: The degree of R&D internationalisation has a positive influence on firms' innovation success.
Following the line of reasoning that increased international R&D decentralisation implies the loss of economies of scale and scope, the higher likelihood of redundant innovation projects and higher transaction costs, we formulate hypotheses H3b and H4b which state that these costs outweigh the gains due to better access to foreign knowledge:
H3b: The degree of R&D internationalisation has a negative influence on the likelihood of introducing innovations (innovation outcome).
H4b: The degree of R&D internationalisation has a negative influence on firms' innovation success.
A rejection of hypothesis H3a would lead to the conclusion that the costs outweigh the benefits of international R&D activities and thus speak in favour of hypothesis H3b. Due to lack of data and similar to Singh (2008) , we cannot test hypotheses about the other moderating factors, i.e. about the effect of subsidiaries' mandates and internal organisational mechanisms to transfer knowledge across different R&D units within the firm efficiently.
Instead we will draw indirect inference on these matters based on our results.
Empirical Analysis
Data Set
To test our hypotheses, we employ data from the Mannheim Innovation Panel ( 
Dependent Variables
We define two sets of dependent variables, following the approach many other studies have used to analyse the effect of firms' national R&D activities on innovation success (see e.g. Griffith et al., 2006; Parisi et al., 2006) . That is, we first investigate whether a firm has introduced new products in the period 2006 to 2008. According to the Oslo Manual, these new products could be either new to the market (market novelties) or new to the firm only (firm novelties), i.e. they greatly differ in their degree of novelty. We suppose that foreign R&D is more crucial for developing market novelties. Thus, we additionally differentiate between two binary variables, namely market novelties and firm novelties.
Given that the firm has introduced a product innovation, market and firm novelty, respectively, we investigate the market success with these innovation outcomes in a similar manner as it has been done by a variety of studies before (Criscuolo and Haskel, 2003; Mairesse and Mohnen, 2005; Jefferson et al., 2006) . In contrast to these studies that define innovation success by the share of sales in a given year due to innovations in the prior three years, we employ a dynamic success measure that accounts for sales changes as proposed by Harrison et al. (2008 
Explanatory Variables
The literature on innovation performance has identified the following main factors that influence innovation output: (i) firms' actual innovation effort, (ii) technological capabilities describing the degree of technological accumulation and efficiency in the innovative search process, (iii) absorptive capacities, and (iv) the use of external knowledge.
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In this regard, the importance of continuous internal R&D activities as an indicator for innovative capabilities and absorptive capacities has been emphasised by many scholars. Becker and Peters (2000) for instance have shown that firms with pronounced absorptive capacities are more likely to have higher sales with new products.
Domestic and Foreign R&D Activities
Our study is aimed at comparing the effect of domestic and foreign R&D on firms' future innovation outcome and market success with innovations. In a second step, we further subdivide international R&D performers according to their degree of R&D internationalisation. We create three binary variables indicating the intensity of firms' foreign R&D engagement by using the number of countries in which the firms carry out R&D activities. A firm is defined to have centralised, medium decentralised and decentralised foreign R&D activities if it performs R&D in one, two to three and more than three foreign countries, respectively. A detailed list of variable definitions is provided in Table 2 .
Control Variables
In addition to dummies indicating the location of R&D activities, we include R&D intensity 
Industry
Industry classification is based on Legler and Frietsch (2007) High R&D-intensive manufacturing 1 if the firm belongs to high R&D intensive manufacturing (NACE 3 digit: 233, 242, 244, 296, 300, (321) (322) (323) (331) (332) (333) 353) Medium R&D-intensive manufacturing 1 if the firm belongs to medium R&D intensive manufacturing (NACE 3 digit: 241, 246, 251, 291, (293) (294) (295) 311, 312, (314) (315) (316) 334, 341, 343, 352 ) Low R&D-intensive manufacturing 1 if the firm belongs to low R&D intensive manufacturing (NACE 3 digit: 150-455, except for those industries already counted as high and medium R&D intensive manufacturing)
Knowledge-intensive services 1 if the firm belongs to the knowledge-intensive service sectors (NACE 3 digit: 221, 523, 603, 611, 622, 623, 643, 651, 652, 660, 671, 701, (721) (722) (723) (724) (725) (726) 731, 732, (741) (742) (743) (744) (921) (922) (923) (924) (925) Other services (reference group) 1 if the firm belongs to other service sectors (not counted as knowledge-intensive service sector)
Besides proxies for innovation effort, technological capabilities, absorptive capacity and use of external knowledge, we control for the effect of a variety of additional variables. We include firm size (number of employees in 2005, in log.), firm location (dummy variable that is 1 if the firm is located in East Germany) as well as the ownership structure of the firms.
That is, we distinguish whether the firm is a single entity (reference category), part of a national group, part of an international group with a German headquarter or an international group with headquarter abroad. Nelson (1959) stressed that more diversified firms possess more opportunities for exploiting new knowledge and complementarities among their diversified activities (economies of scope in innovation) and therefore tend to be more innovative. The degree of product diversification might also indicate the level of firm knowledge and skills (Vermeulen and Barkema, 2002 
Descriptive Statistics
After merging the 2006 and 2009 survey via the identification number of firms we retrieve a sample of 2118 innovation active firms in Germany. The descriptive statistics in Table 5 R&D activities show a higher innovation outcome and given the introduction of a new product they are also more successful on the market with these products compared to firms with domestic R&D, firms with innovations but no own R&D and firms without any innovation efforts in 2005. This is particularly evident for firm novelties, less so for market novelties. Since these differences might also capture the effect of other firm-level variables or industry effects, we carry out an econometric analysis. Sales growth due to new products Sales growth due to firm novelties Sales growth due to market novelties Notes: Innovation outcome is measured as the share of firm that have introduced an innovation. Innovation success is measured as the average sales growth rate due to each type of product innovation.
Estimation Method
To test our hypotheses we estimate three knowledge production functions (Griliches, 1986) , one for each type of innovation (product innovation, market novelties, firm novelties). Since market success with innovations can only be observed if the firm has introduced an innovation, we carry out the two-step estimation procedure proposed by Heckman (1976 Heckman ( , 1979 . The selection equation estimates the effects of the explanatory variables on the likelihood to launch innovations (innovation outcome). Given the introduction of an innovation, the second step of the Heckman estimation is designed to estimate the impact of the explanatory variables on the growth of sales due to this innovation outcome (structural equation).
Firm size and the degree of product diversification serve as exclusion restriction. That is, we include them in the selection equation but exclude them from the structural equation. This partial overlap of the explanatory variables in the selection and structural equation ensures that the identification of parameters does not solely rely on functional form assumptions. The validity of these exclusion restrictions cannot be formally tested (see Wooldridge, 2005) . However, they seemed to be justified since when including the full set of variables in both equations the two variables are significant in the selection equation but have no significant effects in the structural equation (see Table 8 and Table 7 for results of marginal effects). Table 3 and Table 4 Figures show the marginal effect defined as conditional expectation. Table 10 and Table 11 in the annex section of the paper present a robustness check of the previous estimations by eliminating firms from the sample that belong to a group with headquarter abroad.
Empirical Results
Innovation Outcome of International R&D Activities
The estimates show that the influence of international R&D locations is significantly positive on all innovation outcome measures. Domestic R&D activities turned out to be conducive to innovation outcome as well. On the other hand, firms without any innovation activities in the year 2005 are significantly less (negative) likely to develop and to introduce new products in the following period 2006-2008. Having said this, our prime intention was to compare firms with domestic versus international R&D activities. We thus statistically test on equality between both effects. As can be gauged from the F-test, the effects of domestic R&D and R&D abroad are significantly different from each other. Firms with international R&D activities exhibit a significantly higher propensity to introduce product novelties, market novelties and firm novelties. The relative difference between the marginal effect of national and international R&D is greatest for market novelties, which is also reflected in the test statistics (significant at the 1% level (0.009)). The influence of international R&D activities on new product development and firm novelties is about one third larger than the effect of domestic R&D activities. Overall, the results strongly confirm our first hypothesis and thus the assumptions of the knowledge-based view that multiple locations offer firms attractive sources of knowledge. In addition, the results suggest that foreign subsidiaries are actually carrying out knowledge sourcing tasks and that foreign knowledge is successfully integrated into the innovation process of the whole firm.
The empirical analysis further reveals intriguing results regarding the impact of the degree of R&D internationalisation on innovation outcomes (Table 6 ). On the one hand, it turns out that innovation outcome is positively related to the degree of R&D internationalisation. That is, the propensity to introduce products new to the market and new to the firm increases with the degree of decentralisation. Firms with medium decentralised foreign R&D activities have a significantly higher likelihood to develop both market and firm novelties compared to firms with only one foreign subsidiary (centralised foreign R&D). Comparing firms that have medium decentralised and decentralised foreign R&D activities, the results are not clear-cut.
A more decentralised foreign R&D organization does not exert an additional stimulating effect on the propensity to develop market novelties. On the other hand, it further increases the likelihood to develop firm novelties. Actually, we could not retrieve marginal effects for the effect of firms with decentralised foreign R&D on the likelihood to generate new products and firm novelties. The underlying reason is that all firms in our sample that have a high degree of R&D internationalisation (R&D departments in more than three countries) have product innovations and firm novelties. The explanatory variable therefore predicts innovation outcome perfectly and the observations are dropped. These findings mainly support our hypothesis H3a in which we expected that innovation outcome increases with the degree of R&D internationalisation. Comparing our results with studies examining the effect of nationally dispersed R&D activities, we have to ascertain that our results contradict the findings of Argyres and Silverman (2004) who found a U-shaped relationship. They are in line with Leiponen and Helfat (2010) who find that two domestic R&D locations are most beneficial to product and process innovations as well as to any kind of innovation. Another interesting result emerges when we compare firms with domestic R&D and internationally dispersed R&D activities. It turns out that firms with domestic R&D and centralised foreign R&D do not significantly differ in their propensity to develop new products, neither market novelties nor firm novelties. The prior finding that firms with foreign R&D activities benefit much more in terms of innovation outcome than domestic R&D performers is thus mainly driven by firms with medium or decentralised international R&D activities. The robustness check (in Table 10 and Table 11 in the annex section) of these results in which we run the same estimations but on a sample which does only include national firms approve all results for innovation outcomes of domestic and international innovating firms.
Innovation Success of International R&D activities
We secondly investigate the effect of international R&D activities on the innovation success measured by the sales growth due to new products, market novelties and firm novelties.
Columns 3, 5 and 7 of Table 4 present average marginal effects for the expected value of the corresponding sales growth rates conditional on being selected. The estimates reveal that firms with international R&D activities exhibit higher product innovation success than firms without R&D. Compared to firms that solely perform domestic R&D, they also tend to achieve higher sales growth due to new products although the difference is not statistically significant (p-value of a one-sided test: 0.112). These overall results for product innovations are mainly driven by firm novelties. On the contrary, we cannot ascertain significant results regarding the innovation success with market novelties. Given the introduction of a market novelty, firms with international R&D activities do not outperform other firms. That is, once a firm has introduced a market novelty, the location of R&D activities does not matter for innovation success. Overall, these findings do not confirm our second hypothesis in which we anticipated that firms with international R&D activities will achieve higher innovation success than firms with only domestic R&D activities.
Investigating the impact of different degrees of international R&D decentralisation on innovation success with new products, we find a strong non-linear effect. Firms with medium decentralised R&D abroad achieve a higher sales growth with new products than firms which conduct R&D at home only. The difference is statistically significant. Interestingly, they also outperform firms with highly decentralised R&D activities. Overall, medium decentralised international R&D turns out to be most beneficial. As before, this finding is mainly driven by firm novelties, not by market novelties. That is, given the introduction of a market novelty, the degree of decentralisation of international R&D activities does not play a role for innovation success. In this vein, we neither can confirm our hypothesis H4a nor H4b.
However, our results are in line with Leiponen and Helfat (2010) . They find a positive significant impact for firms with two domestic R&D locations on the share of sales with product innovations. The results for prior non-innovative firms show a negative significant effect for the sales growth with firm novelties.
In comparison with the innovation outcome estimations we obtain fewer significant results in our innovation success analysis. One possible explanation can be that much more departments than R&D alone are involved until innovations are ready for the market. However, as was put forward by Singh (2008) , it might also well be that foreign R&D activities do not lead to a higher quality of innovations and therefore limit their market success.
Foreign R&D of German subsidiary firms that belong to an international group with headquarter abroad might be quite different compared to foreign R&D of German firms with headquarter in Germany. However, the robustness check corroborates that the positive effects of (domestic and) international R&D activities is not driven by the former group of firms.
Overall, the robustness estimates show a few less significant effects: the weak significance of domestic R&D on sales growth due to new products as well as the weak significant effect of centralised international R&D on sales growth due to firm novelties vanishes. Notes: See Table 3 .
Estimation Results of Control Variables
Overall, the estimates highlight the stimulating role of innovative capabilities for innovation outcome. Both firms' R&D intensity and share of high skilled employees increase the likelihood of developing firm and market novelties. With respect to R&D intensity, we find a non-linear effect for all kinds of innovations.
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Interestingly, we do not find a significant impact of non-R&D innovation intensity on innovation outcome. Firms that have a higher degree of product diversification are furthermore more likely to introduce new products. Past export activities turn out to be conducive to future innovation activities as we find significant effects for all kinds of product innovation. The ownership of firms shows varying results. We do not find any significant differences between unaffiliated firms, national groups and firms belong to a multinational group with headquarter in Germany. On the contrary, international firms which are headquartered abroad are less likely to introduce firm and market novelties.
Regarding the competitive environment, we find a negative effect of price competition on the introduction of firm novelties and product innovations, but no impact of technology competition on innovation.
Innovation success is driven by the firms' R&D and non-R&D innovation intensity (in case of market novelties). The results further indicate that firms belonging to a multinational group with headquarter abroad achieve higher innovation success with market novelties than other firms. Firm location, in our estimations defined as whether the firm is located in the eastern part of Germany, has an ambiguous effect. On the one hand, firms located in East Germany are less likely to introduce market novelties and they benefit less in terms of innovation success. On the other hand, they outperform West German firms regarding the sales growth due to firm novelties. Firms that operate their businesses in a competitive environment that is characterised by price competition develop not only less firm novelties they also achieve a lower sales growth rate with these new products.
Conclusions
Central objective of this paper was to examine whether international R&D activities are conducive to innovation performance. We investigated whether firms with R&D activities outside their home country benefit from these ventures in terms of a better innovation outcome and higher innovation success. We furthermore analysed how the degree of R&D internationalisation, in terms of the decentralisation into various countries, moderates firms' innovativeness and innovation success. To show the benefits of a strategy to disperse R&D across foreign countries, we compared the estimation outcomes with the results of firms that solely perform R&D within the borders of their home country and non-R&D performing firms. Against the background of the trend to expand R&D facilities globally, our results are useful for firms to decide whether to internationalise their R&D activities at all as well as to extend their existing overseas R&D locations. The literature review of this study has revealed that the few existing studies have maybe answered the question of international R&D benefits insufficiently by relying only on patent data. This paper contributes to the literature by adding information about innovation outcomes that would not be captured by patent data, such as firm novelties and overall product innovations, as well as probably a certain share of market novelties. Moreover, we have also related the added value of international R&D activities to the market success with innovations.
Our results show that firms that follow the trend and internationalise R&D activities have a great potential to strengthen their innovation performance. Firms with international R&D have a higher probability to develop product, market and firm novelties in comparison to firms that perform only domestic R&D or non-R&D performers. However, regarding the innovation success, the results are not as clear-cut. Given the introduction of a firm novelty, firms with international R&D centres are also more successful than non-R&D performers and tend to be more successful than firms conducting domestic R&D. On the contrary, the findings highlight that the location of R&D does not matter for the success of market novelties once the market novelty has been launched to the market.
In our analysis, we also investigate how the number of locations affects innovation outcome and innovation success. The econometric results disclose an inverse u-shaped relationship.
That is, a moderate number of R&D locations abroad is the most beneficial strategy for generating innovation outcomes (product innovations, market and firm novelties). The same conclusion can be drawn for the sales growth due to new products and firm novelties. Another salient finding originates from this analysis: Firms that have expanded their R&D only to one foreign country do not outperform firms with domestic R&D. Admittedly, we cannot say whether this is a general picture or whether this is due the fact that many of these firms might have just recently started to internationalise their R&D and are therefore still in a learning phase. This question is put on the agenda for future research.
To sum up, international R&D seems to ease the access to new knowledge which evidently results in a higher probability of developing innovations and therefore contributes to firms'
competitiveness. Due to a lack of data, we cannot observe how knowledge is transferred and integrated within a multinational firm across countries. But based on our findings, we can conclude that on average firms with international R&D activities have successfully installed knowledge transfer methods to channel foreign knowledge from global subsidiaries back to the home country. Our results also emphasise the perspective that international R&D activities seem to complement existing research efforts. However, for the decision to set up R&D facilities at foreign subsidiaries, managers should carefully choose the specific locations and limit the number to a moderate extent. 
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